Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Elanco Animal Health Incorporated Common Stock (NY:ELAN)

22.06 -0.03 (-0.14%)
Streaming Delayed Price Updated: 10:15 AM EST, Dec 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Elanco Animal Health Incorporated Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
News headline image
Why Kindred Biosciences Stock Skyrocketed Today ↗
The pet therapeutics pioneer is being scooped up by a global animal health leader. 
Via The Motley Fool
News headline image
Why Kindred Biosciences, Aprea, Catabasis And Inhibikase Are Moving Today ↗
Kindred Biosciences, Inc. (NASDAQ: KIN), Aprea Therapeutics, Inc. (NASDAQ: APRE), Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB) and Inhibikase Therapeutics, Inc. (NASDAQ: IKT)... 
Via Benzinga
News headline image
Mid-Day Market Update: Dow Falls 40 Points; Aprea Therapeutics Shares Surge ↗
Midway through trading Wednesday, the Dow traded down 0.12% to 34,259.48 while the NASDAQ rose 0.20% to 14,100.31. The S&P also fell, dropping 0.05% to 4,244.41. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
Elanco Is Looking To Challenge Zoetis, Will The $440 Million Kindred Buyout Help? ↗
Elanco Animal Health said Wednesday it would buy Kindred Biosciences for roughly $440 million, sending KIN stock soaring. 
Via Investor's Business Daily
News headline image
Mid-Morning Market Update: Markets Mixed; Elanco Animal Health To Acquire Kindred Biosciences ↗
Following the market opening Wednesday, the Dow traded down 0.15% to 34,247.35 while the NASDAQ rose 0.36% to 14,123.49. The S&P also fell, dropping 0.01% to 4,246.07. The U.S... 
Via Benzinga
Topics Stocks
News headline image
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
Via Benzinga
News headline image
Kindred Biosciences Stock Jumps On $440M Elanco Animal Buyout Deal ↗
Elanco Animal Health Incorporated (NYSE: ELAN) has agreed to acquire Kindred Biosciences Inc (NASDAQ: KIN) for $9.25 per share, or approximately $440 million... 
Via Benzinga
News headline image
Elanco Announces Agreement to Acquire Kindred Biosciences
From Elanco Animal Health Incorporated
Via Business Wire
News headline image
Elanco Animal Health's Debt Overview ↗
Over the past three months, shares of Elanco Animal Health (NYSE:ELAN) rose by 14.38%. Before we understand the importance of debt, let us look at how much debt Elanco... 
Via Benzinga
News headline image
Elanco Releases Environmental, Social and Governance (ESG) Summary
From Elanco Animal Health Incorporated
Via Business Wire
News headline image
Elanco To Exit Three Manufacturing Sites To Streamline Footprint ↗
Following the acquisition of Bayer Animal Health, Elanco Animal Health Incorporated (NYSE: ELAN) has agreed to sell its sites in Shawnee, Kansas, and Speke,... 
Via Benzinga
News headline image
Elanco Announces Exit of Three Manufacturing Sites, Streamlining Footprint
From Elanco Animal Health Incorporated
Via Business Wire
News headline image
Elanco Announces Addition of Marcela A. Kirberger as General Counsel and Corporate Secretary
From Elanco Animal Health Incorporated
Via Business Wire
Social Distancing Creates Pet-Buying Boom that Sends the Industry to New Heights
Via FinancialNewsMedia
News headline image
The Daily Biotech Pulse: Moderna's Vaccine Authorized In Japan, Neovasc's Adverse Ruling In Germany, Metacrine Rallies On Insider Buying ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 20) Alexion Pharmaceuticals, Inc... 
Via Benzinga
News headline image
Elanco to Participate in Upcoming Investor Conferences
From Elanco Animal Health Incorporated
Via Business Wire
News headline image
The Daily Biotech Pulse: Iovance To Delay Regulatory Filing For Cancer Therapy, Departures At Passage Bio, Positive Readout For Silence Therapeutics ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 18) Alexion Pharmaceuticals, Inc... 
Via Benzinga
News headline image
Q1 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios ↗
The latest round of 13F filings from institutional investors is out, revealing to the world the stocks that some of the richest and most successful investors have been buying and... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17) Alexion Pharmaceuticals, Inc... 
Via Benzinga
News headline image
Last Week's Notable Insider Buys: Activision, Avis Budget, Energy Transfer And More ↗
Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty or are near all-time highs. A couple of chief executive officers and... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2021 ↗
Upgrades For CEVA Inc (NASDAQ:CEVA), Barclays upgraded the previous rating of Equal-Weight to Overweight. For the first quarter, CEVA had an EPS of $0.01, compared to year... 
Via Benzinga
News headline image
Elanco Launches Product for U.S. Poultry Producers, Providing a Flexible Option for Cocci Control
From Elanco Animal Health Incorporated
Via Business Wire
News headline image
ELANCO ANIMAL HEALTH INC (ELAN) Q1 2021 Earnings Call Transcript ↗
ELAN earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Elanco Shares Rise After Q1 Earnings Exceed Expectations, Raises FY21 Outlook ↗
Elanco Animal Health Inc (NYSE: ELAN) has reported Q1 EPS of $0.37 higher than $0.13 reported a year ago. It surpassed analysts' estimate of $0.23 and... 
Via Benzinga
News headline image
Elanco Animal Health Reports First Quarter 2021 Results
From Elanco Animal Health Incorporated
Via Business Wire
News headline image
Earnings Preview for Elanco Animal Health ↗
Elanco Animal Health (NYSE:ELAN) will be releasing its next round of earnings this Friday, May 07. For all of the relevant information, here is your guide for Friday's Q1 earnings... 
Via Benzinga
News headline image
Elanco Animal Health Introduces First Oral Flea and Tick Product for Cats, Credelio® CAT (lotilaner)
From Elanco Animal Health Incorporated
Via Business Wire
News headline image
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:... 
Via Benzinga
News headline image
Earnings Scheduled For May 7, 2021 ↗
Companies Reporting Before The Bell • Cronos Group (NASDAQ:CRON) is likely to report earnings for its first quarter. • Eaton Vance Municipal (NYSE:ETX) is... 
Via Benzinga
News headline image
A Product Recall Crashed Elanco's Stock. Is This a Buying Opportunity? ↗
Elanco's share price has come under pressure amid new concerns over a key product. 
Via The Motley Fool
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.